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Abstract: In the central nervous system (CNS), the expression of molecules is strictly regulated during development. 
Control of the spatiotemporal expression of molecules is a mechanism not only to construct the functional neuronal net-
work but also to adjust the network in response to new information from outside of the individual, i.e., through learning 
and memory. Among the functional molecules in the CNS, one of the best-studied groups is the neurotrophins, which are 
nerve growth factor (NGF)-related gene family molecules. Neurotrophins include NGF, brain-derived neurotrophic factor 
(BDNF), neurotrophin 3 (NT-3), and NT-4/5 in the mammal. Among neurotrophins and their receptors, BDNF and tro-
pomyosin-related kinases B (TrkB) are enriched in the CNS. In the CNS, the BDNF-TrkB signaling pathway fulfills a 
wide variety of functions throughout life, such as cell survival, migration, outgrowth of axons and dendrites, synaptogene-
sis, synaptic transmission, and remodeling of synapses. Although the same ligand and receptor, BDNF and TrkB, act in 
these various developmental events, we do not yet understand what kind of mechanism provokes the functional multiplic-
ity of the BDNF-TrkB signaling pathway. In this review, we discuss the mechanism that elicits the variety of functions 
performed by the BDNF-TrkB signaling pathway in the CNS as a tool of pharmacological therapy. 
Key Words: Brain-derived neurotrophic factor, development, intracellular signaling, morphology, neural plasticity, neuron-glia 
interaction, receptor dimerization, truncated TrkB-T1. 
INTRODUCTION 
  The  neurotrophins  are  the  nerve  growth  factor  (NGF)-
related gene family molecules, including NGF, brain-derived 
neurotrophic  factor  (BDNF),  neurotrophin-3  (NT-3),  and 
NT-4/5. In the central nervous system (CNS), neurotrophins 
are expressed from the early embryonic stage  to the  adult 
stage and regulate a wide variety of functions, such as cell 
migration,  outgrowth  of  neurites,  synaptogenesis,  cell  sur-
vival and death, neuronal transmission, and synaptic plastic-
ity [24,59,66,83,106,115,125]. These physiological functions 
of neurotrophins are induced by their specific receptors ex-
pressed on target cells. The neurotrophin receptors are cate-
gorized into two groups based on their binding affinities for 
neurotrophins [10,18]. One is the high-affinity tropomyosin-
related kinase (Trk) receptor family, which includes TrkA, 
TrkB,  and  TrkC.  NGF  specifically  recognizes  TrkA,  both 
BDNF and NT-4/5 are ligands for TrkB, and NT-3 binds to 
all  Trks,  although  TrkC  mediates  the  primary  biological 
functions of NT-3. Another is low-affinity p75 neurotrophin 
receptor that is one of tumor necrosis factor (TNF) receptor 
family. This receptor can bind to all neurotrophins and en-
hance or suppress Trk signaling by the interaction between 
Trk and p75 [15], and transduce its own signals that regulate 
cell apoptosis or survive [28,110]. 
  How do neurotrophins elicit their various functions? One 
way is by combining signal transducers [115]. Trks and p75 
have many associated proteins that are the starting points of 
their  signaling  cascades  [59,106,110,115].  These  adaptors  
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uniformly exist from early stages to adulthood and can trans-
mit  the  signals  of  other  growth  factors,  neurotransmitters, 
and  hormones  [31,80].  The  associated  proteins  of  all  Trk 
receptors closely resemble each other [59,106,115], so the 
differences in adaptor protein combination can not explain 
not only the characteristic function of each neurotrophin but 
also developmental changes of neurotrophin functions. 
  Another  possible  mechanism  by  which  neurotrophins 
elicit functions is the alternative splicing of the neurotrophin 
receptors. Generally, alternative splicing makes it possible to 
produce functionally distinct proteins that participate in di-
verse cellular processes, including differentiation and devel-
opment [45,120]. Among Trk and p75 receptors,  there are 
some alternative spliced forms [10,110]. Recent studies have 
revealed  that  splice  variants  of  Trk  receptors  function  as 
dominant negative forms [32,42,47,70,92], or they have dis-
tinct functions  via  their original signaling pathway [11,93, 
96,98,109].  In  this  review,  we  focus  on  TrkB  receptor, 
whose splice variants have been well studied, and discuss a 
new aspect of TrkB signaling for neural functions. 
STRUCTURES OF TRKB ISOFORMS 
  Among neurotrophins and their Trk receptors, BDNF and 
TrkB are enriched in the CNS [66], and they play a pivotal 
role in neural plasticity during development and in adulthood 
[19]. TrkB is a single-pass transmembrane molecule. Alter-
native  splicing  of  the  TrkB  pre-mRNA  from  the  locus  on 
DNA yields at least two isoforms (Fig. 1) [86]. One is a full-
length form of TrkB, which has the tyrosine kinase domain 
in the cytosolic region and is designated as TK+. The ex-
tracellular domain of TK+ possesses three tandem leucine-
rich  repeats  flanked  by  two  distinct  cysteine-rich  domains 
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for ligand binding, from the N-terminal [10]. Another is the 
tyrosine kinase lacking isoforms, TK-, which consists of two 
isoforms, T1 and T2. These truncated isoforms contain the 
same extracellular domain, transmembrane domain, and ini-
tial 12 intracellular amino acid sequences as TK+, but they 
have the specific C-terminal sequences (11 and 9 amino acid 
residues,  respectively)  [10].  Interestingly,  the  C-terminal 
sequence of T1 is completely conserved in mammals, such 
as mice, rats, and humans [67,86,118], suggesting that this 
sequence is essential for this isoform’s function. On the other 
hand, it remains unclear if T2 is expressed in mice and hu-
man, since the T2 sequence has been detected only in rats 
[67,74,86,118]. 
EXPRESSION  OF BDNF AND  TRKB ISOFORMS IN 
THE CNS 
  BDNF is a secreted glycoprotein that is released from the 
pre- and postsynaptic terminals [3,36,37,51,71]. Importantly, 
the synthesis of BDNF is up-regulated in a neuronal activity-
dependent manner. BDNF mRNA and protein are both de-
tected in many  CNS regions, such as  the neocortex,  amy-
gdala, thalamus, hypothalamus, pituitary gland, and substan-
tia  nigra,  suggesting  an  autocrine  and  paracrine  mode  of 
BDNF in those regions [57,132,133]. On the other hand, the 
synthetic and functional sites of BDNF are sometimes differ-
ent.  For example, the striatum  contains  BDNF protein but 
does not express BDNF mRNA. A previous study showed 
the  anterograde transport of  BDNF from  the  cortex  to the 
striatum [5]. Among the CNS regions, hippocampal forma-
tion has been studied the most. In the rat, the dense positive 
structures of BDNF mRNA were observed in all regions of 
the hippocampus [33,62], but no immunoreactivity was found 
in the granule cell bodies or CA1 regions [132]. However, 
the mossy fiber layer was densely immunopositive for BDNF. 
One hypothesis is that BDNF mRNA is antero-gradely trans-
ported  to  the  axons  and/or  dendrites  of  granule  cells  and 
CA1 pyramidal neurons, and locally translated to BDNF pro-
tein [19,64]. In contrast, both mRNA and protein of BDNF 
are expressed in all subregions of the monkey hippocampus 
[55,102,133]. In addition,  the  expression pattern of BDNF 
mRNA in the human hippocampus shows good similarity to 


















Fig. (1). Schematic representation of TrkB isoforms. 
(A) Structures of TrkB isoforms are shown. The extracellular domain (i.e., cysteine-rich, leucine-rich, cysteine-rich, and two immunoglobu-
lin-like domains), transmembrane domain, and initial 12 intracellular amino acid sequences are the same as those of T1 and T2. Truncated 
forms T1 and T2 possess 11 and 9 specific amino acid sequences, respectively. The dotted square indicates the specific sequences of trun-
cated forms of TrkB, shown in B. (B) Comparison of intracellular amino acid sequences of TrkB isoforms. The parts shown in the square are 
transmembrane domains of TrkB isoforms. Specific amino acid sequences of T1 and T2 are underlined. In A and B, the T2-specific intracel-
lular sequence is reported in the rat cerebellum. 278    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
BDNF  expression between rodents and primates  may sug-
gest different functions of BDNF in these species. 
  Previously, many studies of TrkB distribution focused on 
TK+  [6,20,131],  because  it  is  difficult  to  detect  the  im-
munoreactivity of T1. Since the T1 C-terminal is identical in 
mammals, as described above, the production of anti-T1 an-
tibody is quite difficult. Recently, our group established the 
immunohistochemistry  for  T1,  by  the  treatment  with  gua-
nidine HCl (pH 11) that recovers the antigenicity of T1 [93-
95,98,101]. The antibody of T1 recognizes the C-terminal 12 
amino acid sequence that interacts with Rho GDI1, suggest-
ing that the associated protein of T1 Rho GDI1 inhibits the 
interaction between T1 and anti-T1 antibody. The treatment 
with guanidine may dissociate the binding between T1 and 
Rho GDI1 or denature Rho GDI1, and then the antigenicity 
of T1 would be recovered. 
  As a result of previous immunohistochemical and in situ 
hybridization studies of TK+ and T1, researchers now know 
that both TK+ and T1 are widely distributed in all regions of 
the adult CNS, including the neocortex, cerebellum, hippo-
campus,  amygdala,  basal  ganglia,  septal  region,  thalamus, 
hypothalamus,  midbrain,  brainstem,  and  spinal  cord  [9,12, 
20,41,53, 54,94,95,101,108,131]. On the other hand, western 
blot analysis with each antibody of TK+ and T1 has shown 
that the distributions of those molecules overlap considera-
bly  in  almost  all  regions  of  the  CNS  in  adulthood  [2,41, 
70,94,95,99,100,101]. 
CELLULAR  EXPRESSION  OF  BDNF  AND  TRKB 
ISOFORMS 
  In light of the expressions of TK+ and T1 at the cellular 
level, experiments have clarified that each expression pattern 
is considerably different from the other. In the neocortex of 
the  adult  rat,  TK+  is  detected  in  pyramidal  neurons  and 
GABAergic  interneurons,  whereas  the  expression  of  T1  is 
observed in not only neurons but also astrocytes [97,101]. 
Similar  results  were  obtained  at  the  TK+  and  T1  mRNA 
level [9,12,40]. Northern blot analysis demonstrated that TK- 
is  expressed  in  neurons,  astrocytes,  and  oligodendrocytes, 
whereas  TK+  transcript  is  only  detected  in  neurons  [40]. 
These results suggest that the interaction of TK+ and T1 may 
occur  in  neurons.  In  glias,  T1  is  a  major  isoform  among 
TrkB subtypes and is involved in the function of glias. 
EXPRESSION CHANGES OF BDNF AND TRKB ISO-
FORMS DURING DEVELOPMENT 
  The  expression of  BDNF is observed beginning in the 
mid-stage  of  development  in  the  mammal  [60,89,90,114]. 
For example, in the developing cerebral cortex of the ma-
caque monkey, which has an embryonic period of 165 days, 
BDNF mRNA was not detected before the 110th embryonic 
day (E110d), and the positive signals of BDNF were sparsely 
distributed in neocortical layers by E121d [60]. Also, at the 
protein level, BDNF content was at a low level at E120d, 
and then it gradually increased with the progress of devel-
opment [89]. The level of BDNF protein in the monkey neo-
cortex increased by 2-fold compared to the adult level at the 
early postnatal period, around postnatal 2 months (P2m), and 
decreased thereafter [89]. This increase in BDNF mRNA has 
also  been  reported  in  the  human  neonatal  temporal  cortex 
[129]. This developmental change of BDNF expression was 
also found in the rat occipital cortex, in which BDNF mRNA 
was  at  a  low  level  by  P10d,  started  to  increase  by  5-fold 
compared to the P10d value after the second postnatal week, 
and declined after P30d [114], indicating that this expression 
change of BDNF during development was conserved among 
mammals. 
  The developmental expression of TrkB isoforms exhibits 
a specific pattern [2,70,99]. TK+ is expressed in almost all 
regions of the CNS from the early developmental period, and 
its expression level is maintained into the adult stage. In con-
trast, the T1 expression in the forebrain, such as the neocor-
tex,  hippocampus,  amygdala,  olfactory  bulb,  striatum,  and 
septum, is at a very low level by the early and middle devel-
opmental stages and increases markedly at the late develop-
mental stage, with a high level of T1 expression maintained 
until  the  adult  stage.  Interestingly,  the  inflection  points  of 
both BDNF and T1 expression during development coincide 
well with the period of elimination of excessive axons and 
synaptogenesis [2,51,52,99]. 
DEVELOPMENTAL  CHANGE  OF  TRKB  DIMERI-
ZATION  AND  FUNCTIONS  OF  BDNF-TRKB  SIG-
NALING 
  Neurotrophins  exist  in  vivo  as  a  non-covalently  linked 
homodimeric protein, and the binding of neurotrophin to its 
receptor invokes the receptor dimer [10,18]. The dimeriza-
tion of receptors induces autophosphorylation in the kinase 
domain of the cytosolic region of Trk receptors, followed by 
the  activation  of  various  signaling  pathways,  such  as  the 
Ras/MAP  kinase,  phospholipase  C  (PLC),  and  PI3  kinase 
pathways [24,59,66,106,115]. Thus, the dimerization of Trk 
receptor is very important as a starting point of intracellular 
signaling. It is interesting to know that the pattern of TrkB 
dimerization  changes  during  development  of  the  monkey 
neocortex [100]. 
  In the early developmental stage of the monkey neocor-
tex, when T1 is not expressed, at embryonic day 120 (E120), 
TK+/TK+ homodimer is formed in a ligand-dependent man-
ner  [100],  suggesting  that  the  signaling  pathway  of  TK+ 
mainly works during this period. Then, the adaptor proteins 
that interacted with TK+ are activated by the TrkB ligands 
(BDNF, NT-3,  and NT4/5).  The main  signaling pathways, 
including the PLC-γ1, Ras/MAP, and PI3K pathways, func-
tion in neuronal plasticity, neurite outgrowth  and survival, 
and cell motility, respectively (Fig. 2) [59,106]. The forma-
tion of TK+ homodimer is consistent with the finding that 
these  phenomena  occur  actively  during  the  early  develop-
mental period. In  the  early phase of development,  the ex-
pression  of  BDNF  is  at  a  very  low  level,  while  the  other 
TrkB ligand, NT-3, is expressed at a relatively higher level 
than  its  expression  level  at  the  adult  stage  [90].  Together 
with the fact that NT-3 can induce the dimerization of TrkB 
[100], the NT-3-TK+ signaling pathway might play an im-
portant role in the regulation of the cell cycle and migration 
[44,122]. 
  TK+/TK+  and  T1/T1  homodimers  are  formed  at  the 
newborn  stage  (NB)  of  the  monkey  neocortex  [100].  The 
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commissure has been reported to reach a maximum in NB 
and to decrease to about 75% by P60 [51,52,75,76]. The in-
crease in T1 expression correlates well with the period when 
commissural axons are eliminated and synaptogenesis occurs 
[51,52,75,76,105]. This result suggests that T1 might be in-
volved in the elimination of axons. As possible mechanisms, 
the followings may be considered: 1) the expression of T1 
increases  in  neighbouring  glial  cells  and  T1  in  glial  cells 
absorbs the excess BDNF for axonal pruning, 2) in neurons, 
the  increase  of  T1  induced  the  inhibition  of  the  action  of 
TK+ by the dominant effect of T1. 
  In  the  monkey  neocortex,  the  density  of  synapses  in-
creases after birth, reaches the highest level between postna-
tal 2–4 months in all cortical areas, and decreases to about 
half of the maximum level within several years after birth 
[51,52,105]. The expression of T1 increases remarkably after 
birth [2,70,99]. Interestingly, the dendritic filopodia, which 
are  known  precursors  of  synaptic  spines,  are  induced  by 
overexpression of T1 in hippocampal neurons from postnatal 
rats  [49].  This  outgrowth  of  dendritic  filopodia  is  not  ob-
served  in  TK+-overexpressing  neurons.  Thus,  T1  by  itself 
might be involved in  synaptogenesis,  although the  mecha-
nism is unclear. 
  As described above, T1 participates in axon elimination, 
whereas it exhibits an  increase  in the number of dendritic 
filopodia. This is a contradiction, but it may be explained by 
the difference  in intracellular  localization of TK+ and  T1, 
such as dendrites and axons. In fact, in adult brains, T1 is 
concentrated in the presynaptic site [7,103], whereas TK+ is 
localized in both pre- and postsynaptic regions [7,103,112]. 
In the developing brains, the distributions of TK+  and T1 
might be dynamically changed. 
  At  the  adult  stage,  TK-/TK-  homodimer  and  the 
TK+/TK-  heterodimer  have  been  observed  to  form  in  the 
monkey  cerebral  cortex  [100].  Furthermore,  surprisingly, 
TK+  homodimer  is  not  formed  at  adulthood.  Although  it 
would be very interesting to determine whether the TK+/TK- 
heterodimer can transduce the intracellular signals, T1 may 
function as a dominant negative receptor of TK+ in neurons. 
At the same time, T1 plays an important role in glial cells, 















Fig. (2). TrkB signaling pathways. 
In the neuron, shown in a dotted square, BDNF induces three TrkB dimers: TK+ homodimer, TK+-T1 heterodimer, and T1 homodimer. The 
signaling cascade of TK+ homodimer has been well studied. Activation of PLCγ results in the activation of PKC, which promotes synaptic 
plasticity. Activation of Shc protein induces activation of the PI3K-Akt and Ras-MAP kinase signaling cascades, which regulate cell survival 
and differentiation, respectively. It is unclear whether TK+-T1 heterodimer can transduce the signals. Furthermore, T1 plays an important 
role in synaptic transmission, although the mechanism is not understood. Since T1 homodimer has not yet been observed in neurons, further 
investigation is needed. In the astrocyte, which is shown in a gray square, T1 is a major isoform of TrkB receptors. The binding of BDNF to 
T1 induces T1 homodimer, which results in the release of Rho GDI1 and the morphological changes of astrocytes. Moreover, T1 is involved 
in a Ca
2+ influx in astrocytes. On the other hand, TTIP (truncated TrkB-interacting protein) is a binding protein of T1, but it is not clear 
whether it transduces the signals. 280    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
SIGNALING PATHWAY OF T1 
  T1  had  been  hypothesized  to  be  a  dominant-negative 
form of TK+ because of a lack of the tyrosine kinase domain 
and to be involved in negative functions against TK+, such 
as  TK+  phosphorylation  [70],  calcium  efflux  [31],  neurite 
outgrowth [42], cell survival activity [47], and gene expres-
sion by BDNF [92]. According to this hypothesis, T1 was 
postulated to form a homodimer or heterodimer with TK+, 
which prohibited TK+ signaling or limited the availability of 
BDNF to neurons by trapping excess  BDNF [17]. In con-
trast,  there  were  several  reports  that  provided  evidence 
against the hypothesis that T1 was a dominant-negative form 
of TK+. For  example, several researchers showed that the 
expression  of  T1  increases  markedly  at  various  important 
periods in the developing mammalian CNS, such as axonal 
remodeling and  synaptogenesis [2,41,99,100].  The specific 
alignment  of  the  intracellular  domain  of  T1  is  completely 
identical  among  mice,  rats,  and  humans  [67,86,118],  sug-
gesting that this alignment plays a unique role. In addition, 
T1 is capable of binding to BDNF at the same level as does 
TK+ [17]. Taken together with the fact that T1 has been re-
ported to mediate signal transduction (i.e., the acid metabo-
lite release from cells) [11], these findings raised the possi-
bility that T1 has its own signaling pathway.  
  Recently,  T1  has  been  reported  to  possess  a  signaling 
pathway (Fig. 2) [96,98]. T1 is directly bound to Rho GDI1, 
a Rho guanine nucleotide dissociation inhibitor that can sta-
bilize the inactive, GDP-bound form of Rho GTPase [98]. 
The Rho signaling pathway controls the remodeling of mi-
crofilaments, intermediate filaments,  and microtubules [35, 
121]. In the BDNF-T1 signaling pathway, Rho GDI1 is re-
leased from T1 in a BDNF-dependent manner, which causes 
decreases in the activities of Rho-signaling molecules such 
as  RhoA,  Rho-associated  kinase  (ROCK),  p21-activated 
kinase  (PAK),  and  extracellular-signal  regulated  kinase 
(ERK) 1/2 [96]. Consequently, T1 alters the cell morphology 
of astrocytes in primary cultures and acute slices [93,98]. 
  T1 has been involved in the intracellular Ca
2+ influx in 
astrocytes,  via  PLC>IP3  production  [109].  Since  the  PLC 
pathway plays an important role on neuronal plasticity [119], 
T1 in neurons might participate in this process. 
  Another  binding  protein  of  T1  is  truncated  TrkB-
interacting protein (TTIP), which is isolated from 15N neu-
roblastoma cells by coimmunoprecipitation with GST fusion 
protein  containing  the  intracellular  juxtamembrane  of  T1 
(Fig. 2) [73]. TTIP has a molecular weight of 61 kDa. How-
ever, BDNF stimulation cannot modulate the interaction be-
tween T1 and TTIP. It is also uncertain whether Rho GDI1 
and  TTIP  bind  directly  to  the  different  motifs  in  the  T1-
specific region or compete for the same binding site. Further 
studies on TTIP are needed in the future. 
REGULATION OF CELL MORPHOLOGY BY TRKB 
ISOFORMS 
  One  function  of  the  BDNF-TrkB  signaling  pathway  is 
that it is heavily involved in the regulation of the cell mor-
phology.  BDNF  regulates  the  branching  and  extension  of 
axons and dendrites during development both in vitro and in 
vivo [4,25-27,58,63,79,81,82,84,113]. In addition, treatment 
with  BDNF  increases  in  the  number  of  synapses  [1,4,23, 
113,116,117]. These experiments were performed using de-
veloping dissociated neurons, brain slices, and animals, sug-
gesting that TK+ mainly functioned in neurons in these stud-
ies. In the P14 ferret neocortex, where indeed the expression 
of TK+ is several times that of T1 [2], BDNF administration 
increases  the  length  and  complexity  of  dendrites  [82,84]. 
Interestingly,  the  laminar  specificity  for  neurotrophin  re-
sponse is observed: neurons in layers 4 and 5 to BDNF and 
neurons in layers 5 and 6 to NT-4. In these layers that are 
responsible to TrkB ligands, TK+ like immunoreactivity is 
intensely  detected  at  P10-24.  Thus,  TK+  promotes  axonal 
and dendritic growth during development. 
  Studies of T1 with regard to cell morphology employed 
the strategy of T1 overexpression in cell line and slice cul-
tures. In the N2a cell line, the transient overexpression of T1 
led to a ligand-independent change of cell morphology, such 
as  the  growth  of  filopodia  and  processes  [48].  The  study 
demonstrated that deletion mutants lacking the T1 specific 
intracellular domain induce filopodia and processes, but the 
mutant lacking the extracellular domain failed to have this 
effect.  In  addition,  p75  was  not  involved  in  this  process. 
Thus, the authors suggested that the extracellular domain of 
T1  might  function  as  a  cell  adhesion  molecule.  Another 
study in rat hippocampal primary cultures [49] showed that 
T1 induced the formation of dendritic filopodia, which oc-
curred independent of ligand formation. In contrast, the in-
teraction between T1 and p75 was essential for the induction 
of filopodia.  This  might have been due  to material differ-
ences, such as the cell line [48] or primary cultured hippo-
campal neurons [49]. The study using P14 ferret neocortical 
slice  culture  showed  that  TK+  and  T1  regulated  distinct 
modes of dendritic growth [130]. The transfection of TK+ 
induced  prominent  outgrowth  of  short  dendrites  that  ex-
tended from the  cell body and the proximal region of the 
apical dendrites. In contrast, the transfection of T1 did not 
increase short dendrites near the soma, but it did elevate the 
arborization of distal dendrites. Providing exogenous ligands 
blocked the distal growth of dendrites in T1-transfected neu-
rons. Furthermore, in proximal dendrites, the treatment with 
ligands  decreased  dendritic  complexity  compared  with  the 
control level. Most recently, in T1-deficient mice, morpho-
logical abnormalities in the length and complexity of neu-
rons in the basolateral amygdala were described [21]. Con-
sidering that the expression of T1 increased at the stage of 
synaptogenesis,  T1  might  have  fine-tuned  the  growth  of 
dendrites, axons and synaptic structures, by the interaction 
with TK+. Further examination of the function of T1 in regu-
lating neuronal morphology will be interesting. 
  Most importantly, T1 plays a role on astrocyte functions. 
For example, T1 induced a rapid change of astrocytic mor-
phology via Rho GTPase in primary astrocyte cultures [98] 
and in the rat neocortex layer I [93]. Additionally, T1 con-
trolled calcium entry into astrocytes [109]. Since the release 
of BDNF  is highly regulated by neuronal activity [50,71], 
these findings led us to the idea that BDNF release by neu-
ronal activities induces morphological changes of astrocytes 
in the CNS. Recent studies have shed light on the interac-
tions between neurons and glial cells [38,124,128]. In par-
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into astrocytes modulated synaptic transmission [14,39]. In 
addition,  astrocytic  endfeet  enwrap  synapses  [127],  i.e., 
those  synapses  referred  to  as  tripartite  synapses  [8].  Fur-
thermore,  astrocytic  processes  surrounding  active  synapses 
have  been  described  as  altering  their  morphology  in  the 
brainstem [56], hypothalamus [77], cerebellum [61], hippo-
campus [13], and neocortex [93] of infant- to pubertal-stage 
rodents, suggesting that the tripartite synapse is a common 
structure in the CNS. In contrast, alterations of fine neuronal 
structures such as dendrites and spines in the neocortex of 
adult mice hardly occur under normal conditions [45,126]. 
These findings suggest that the morphological alteration of 
astrocytes may be essential for the maintenance and plastic-
ity of synaptic transmission, as well as for transmitter clear-
ance. Therefore, neuronal and glial structural modifications 
might be regulated by the interaction of TK+ and T1 in neu-
rons and the T1 in astrocytes, respectively. 
TRKB ISOFORMS IN THE SYNAPTIC PLASTICITY 
  BDNF-TrkB  signaling  has  an  effect  on  morphological 
changes of neurons and glias and plays an important role in 
synaptic plasticity [65,72,85,87]. In light of this, we wanted 
to  explore  two  important  issues,  1)  activity-dependent  ex-
pression and secretion of BDNF, and 2) subcellular localiza-
tion of TrkB subtypes, i.e., pre- or postsynaptic sites. 
  Not only in vitro stimulations such as the administration 
of drugs but also physiological stimulations, such as exercise 
[91],  visual  input  [22],  and  whisker  stimulation  [107], 
showed the increase of BDNF expression and secretion. It is 
unclear whether dendritic production of BDNF (i.e., BDNF 
mRNA  targeting to dendrites) and concentration of BDNF 
protein in the secretion vesicles occur in the active synapse 
[51,72]. Furthermore, it has not yet been clarified whether 
BDNF is released from the vesicles in the pre- or postsynap-
tic sites [3,36,37,50,71], like neuropeptide transmitters [111]. 
  TrkB  subtypes  are  widely  distributed  throughout  the 
brain, as described in the previous section. However, consid-
ering that the signaling pathway of TK+ is distinct from that 
of T1, it is important to clarify the subcellular localization of 
TK+ and T1 in neurons. Subcellular fractionation of the rat 
brain showed that 1) both TrkB subtypes were concentrated 
in synaptic membrane fraction [7,94,97,103], 2) TK+ and T1 
exhibited  a  differential  subcellular  distribution;  TK+  was 
present in the presynaptic active zone and postsynaptic den-
sity, while T1 was mainly distributed in the presynaptic ac-
tive zone [7,103]. Interestingly, using cultured hippocampal 
neurons infected with the T1-expressing adenovirus vector, 
Schuman’s  group  demonstrated  that  presynaptic,  but  not 
postsynaptic, expression of T1 inhibited BDNF enhancement 
of  synaptic  transmission,  whereas  activation  of  TrkB-
associated signaling enhanced neurotransmitter release from 
presynaptic terminals [78]. Although pre- and postsynaptic 
modifications are involved in long-term potentiation, at least 
presynaptic T1 might play an important role in the regulation 
of  initial  synaptic  potentiation  between  neurons.  Since  T1 
inhibits  the  phosphorylation  of  TK+,  the  activation  of 
BDNF-TK+  signaling  may  be  required  for  BDNF-induced 
potentiation. On the other hand, Rho GTPases are involved 
in Ca
2+-dependent neurotransmitter exocytosis via the regu-
lation  of  actin  filament  [30,88].  Thus,  the  BDNF-T1-Rho 
GDI1  signaling  cascade  may  regulate  the  neurotransmitter 
release, regulating Rho GTPases activity. 
PHARMACOLOGICAL  USEFULNESS  OF  T1  AS  A 
MOLECULAR SWITCH 
  The  T1  signaling  cascade  challenges  the  conventional 
view that T1 acts as a dominant negative form of TK+. It is 
reasonable  to assume that  T1 could  exert dual roles in  an 
age-dependent  manner  and/or  by  subcellular  and  cellular 
localization. In neurons, T1 could act as a dominant negative 
form  of  TK+  through  the  formation  of  the  TK+/TK-  het-
erodimer in adulthood. In astrocytes, T1 could act as a nega-
tive regulator for the Rho signaling cascade. Thus, T1 may 
be a Janus-faced receptor of BDNF as a “molecular switch.” 
Also, the change of TrkB receptor dimerization may be one 
of the mechanisms generating the variety of biological func-
tions of BDNF during development. 
  If we can control each expression of TrkB subtypes in a 
certain cell type, i.e., in a neuron- or astrocyte-specific man-
ner, by drugs or gene-transferring treatment in the near fu-
ture, the results might be useful in the treatment for psychiat-
ric and neurological diseases, including depression and sui-
cide  [34],  schizophrenia  [104],  and  neurodegenerative  dis-
eases [29]. These studies suggest that it is essential for main-
taining neuronal functions to regulate adequately the expres-
sion of T1. For example, the decrease in expression of T1 is 
observed  in  the  frontal  cortex  of  suicide  completers  [34]. 
Interestingly, the methylation in the trkB promoter regions is 
significantly reduced, which results in only the decrease in 
T1 expression without the change of TK+ expression [34]. In 
the model mouse of schizophrenia, both mRNA and protein 
levels of T1 were significantly higher in the frontal cortex, 
but those of TK+ were not altered [104]. Furthermore, using 
a trisomic mouse model, the suitable expression level of T1 
is important for the survival of neocortical and hippocampal 
neurons.  Taken  together,  pharmaceutical  preparations  to 
regulate the proper expression of T1, such as T1 siRNA and 
cDNA  [93,98]  and  synthetic  peptide  of  T1  specific  C-
terminal sequence [98], will be valuable for the treatment of 
psychiatric and neurological disorders. In addition, the com-
bination use of T1 siRNA and cDNA and cell type-specific 
promoters can be more useful. 
  T1  has  been  shown  to  be  expressed  in  the  neurogenic 
regions [43,123]. Recent study suggests that overexpression 
of T1 increases  the proliferation of neural progenitor cells 
[123]. Interestingly, BDNF has anti-proliferative activity on 
the self-renewal of neural stem cells; however, it also func-
tions as a differentiation factor for stem cells, which are af-
fected by the expression of TK+. Thus, the rate of TrkB sub-
type expression in stem cells is of importance in determining 
the balance between proliferation and differentiation. In vivo 
study  also  showed  that  dopaminergic  periglomerular  in-
terneurons in the olfactory bulb were decreased in TrkB KO 
mice.  Moreover,  calbindin-positive  cells  were  slightly  de-
creased,  compared  with  the  control,  suggesting  that  TrkB 
may play a selective role in regulating the proliferation and 
differentiation of subtypes of specific interneurons [43]. Fur-
thermore, as described in the above sections, TrkB subtypes 
influence neural plasticity via regulation of the neuronal and 
glial  morphology.  Therefore,  the  control  of  BDNF-TrkB 282    Current Neuropharmacology, 2009, Vol. 7, No. 4  Ohira and Hayashi 
signaling  can  regenerate  neurons  and  repair  neuronal  net-
works as therapy following a brain injury such as trauma or 
ischemia. 
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